Bimolecular complementation to visualize filovirus vp40-host complexes in live mammalian cells: Toward the identification of budding inhibitors

Advances in Virology

Volumn 2011, Issue , 2011, Pages

  Liu, Yuliang ^a   Lee, Michael S ^b   Olson, Mark A ^b   Harty, Ronald N ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EBOLA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LAKE VICTORIA MARBURGVIRUS; MAMMALIA; MARBURGVIRUS; RNA VIRUSES;

EID: 84866851227     PISSN: 16878639     EISSN: 16878647     Source Type: Journal    
DOI: 10.1155/2011/341816     Document Type: Article

References (52)

1. Bray M., Defense against filoviruses used as biological weapons. Antiviral Research 2003 57 1-2 53 60 2-s2.0-0037287574 10.1016/S0166-3542(02) 00200-0
2. Hartman A. L., Towner J. S., Nichol S. T., Ebola and marburg hemorrhagic fever. Clinics in Laboratory Medicine 2010 30 1 161 177 2-s2.0-77953351485 10.1016/j.cll.2009.12.001
3. Dolnik O., Kolesnikova L., Becker S., Filoviruses: interactions with the host cell. Cellular and Molecular Life Sciences 2008 65 5 756 776 2-s2.0-40449125013 10.1007/s00018-007-7406-2
4. Harty R. N., Brown M. E., Wang G., Huibregtse J., Hayes F. P., A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proceedings of the National Academy of Sciences of the United States of America 2000 97 25 13871 13876 2-s2.0-0034610295 10.1073/pnas.250277297
5. Johnson R. F., Bell P., Harty R. N., Effect of Ebola virus proteins GP, NP and VP35 on VP40 VLP morphology. Virology Journal 2006 3, article 31 2-s2.0-33746029728 10.1186/1743-422X-3-31
6. Licata J. M., Simpson-Holley M., Wright N. T., Han Z., Paragas J., Harty R. N., Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4. The Journal of Virology 2003 77 3 1812 1819 2-s2.0-0037303193 10.1128/JVI.77.3.1812-1819.2003
7. Licata J. M., Johnson R. F., Han Z., Harty R. N., Contribution of Ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles. The Journal of Virology 2004 78 14 7344 7351 2-s2.0-3142710288 10.1128/JVI.78.14.7344-7351.2004
8. Liu Y., Cocka L., Okumura A., Zhang Y. A., Oriol Sunyer J., Harty R. N., Conserved motifs within Ebola and Marburg virus VP40 proteins are important for stability, localization, and subsequent budding of virus-like particles. The Journal of Virology 2010 84 5 2294 2303 2-s2.0-77649220531 10.1128/JVI.02034-09
9. Noda T., Sagara H., Suzuki E., Takada A., Kida H., Kawaoka Y., Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. The Journal of Virology 2002 76 10 4855 4865 2-s2.0-0036235725 10.1128/JVI.76.10.4855-4865.2002
10. Timmins J., Schoehn G., Ricard-Blum S., Scianimanico S., Vernet T., Ruigrok R. W. H., Weissenhorn W., Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. Journal of Molecular Biology 2003 326 2 493 502 2-s2.0-0037436346 10.1016/S0022-2836(02)01406-7
11. Chen B. J., Lamb R. A., Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology 2008 372 2 221 232 2-s2.0-39549095341 10.1016/j.virol.2007.11.008
12. Dolnik O., Kolesnikova L., Stevermann L., Becker S., Tsg101 is recruited by a late domain of the nucleocapsid protein to support budding of Marburg virus-like particles. The Journal of Virology 2010 84 15 7847 7856 2-s2.0-77954471091 10.1128/JVI.00476-10
13. Kolesnikova L., Strecker T., Morita E., Zielecki F., Mittler E., Crump C., Becker S., Vacuolar protein sorting pathway contributes to the release of marburg virus. The Journal of Virology 2009 83 5 2327 2337 2-s2.0-60049086612 10.1128/JVI.02184-08
14. Urata S., Yasuda J., Regulation of Marburg virus (MARV) budding by Nedd4.1: a different WW domain of Nedd4.1 is critical for binding to MARV and Ebola virus VP40. Journal of General Virology 2010 91 1 228 234 2-s2.0-73149117324 10.1099/vir.0.015495-0
15. Urata S., Noda T., Kawaoka Y., Morikawa S., Yokosawa H., Yasuda J., Interaction of Tsg101 with Marburg virus VP40 depends on the PPPY motif, but not the PT/SAP motif as in the case of Ebola virus, and Tsg101 plays a critical role in the budding of Marburg virus-like particles induced by VP40, NP, and GP. The Journal of Virology 2007 81 9 4895 4899 2-s2.0-34247633960 10.1128/JVI.02829-06
16. Garrus J. E., Von Schwedler U. K., Pornillos O. W., Morham S. G., Zavitz K. H., Wang H. E., Wettstein D. A., Stray K. M., Côté M., Rich R. L., Myszka D. G., Sundquist W. I., Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 2001 107 1 55 65 2-s2.0-17944363138 10.1016/S0092-8674(01)00506-2
17. Goff A., Ehrlich L. S., Cohen S. N., Carter C. A., Tsg101 control of human immunodeficiency virus type 1 Gag trafficking and release. The Journal of Virology 2003 77 17 9173 9182 2-s2.0-0041888375 10.1128/JVI.77.17.9173-9182.2003
18. Irie T., Licata J. M., Harty R. N., Functional characterization of Ebola virus L-domains using VSV recombinants. Virology 2005 336 2 291 298 2-s2.0-18844392879 10.1016/j.virol.2005.03.027
19. Katzmann D. J., Babst M., Emr S. D., Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell 2001 106 2 145 155 2-s2.0-0035958546 10.1016/S0092-8674(01)00434-2
20. Martin-Serrano J., Zang T., Bieniasz P. D., Role of ESCRT-I in retroviral budding. The Journal of Virology 2003 77 8 4794 4804 2-s2.0-0037383128 10.1128/JVI.77.8.4794-4804.2003
21. Martin-Serrano J., Zang T., Bieniasz P. D., HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nature Medicine 2001 7 12 1313 1319 2-s2.0-0035658023 10.1038/nm1201-1313
22. Pincetic A., Medina G., Carter C., Leis J., Avian sarcoma virus and human immunodeficiency virus, type 1 use different subsets of ESCRT proteins to facilitate the budding process. The Journal of Biological Chemistry 2008 283 44 29822 29830 2-s2.0-57649158619 10.1074/jbc.M804157200
23. Chung H.-Y., Morita E., Von Schwedler U., Müller B., Kräusslich H.-G., Sundquist W. I., wes@biochem.utah.edu NEDD4L overexpression rescues the release and infectivity of human immunodeficiency virus type 1 constructs lacking PTAP and YPXL late domains. The Journal of Virology 2008 82 10 4884 4897 10.1128/JVI.02667-07
24. Yasuda J., Nakao M., Kawaoka Y., Shida H., Nedd4 regulates egress of Ebola virus-like particles from host cells. The Journal of Virology 2003 77 18 9987 9992 2-s2.0-0141570508 10.1128/JVI.77.18.9987-9992.2003
25. Atanasiu D., Whitbeck J. C., Cairns T. M., Reilly B., Cohen G. H., Eisenberg R. J., Bimolecular complementation reveals that glycoproteins gB and gH/gL of herpes simplex virus interact with each other during cell fusion. Proceedings of the National Academy of Sciences of the United States of America 2007 104 47 18718 18723 2-s2.0-36749035394 10.1073/pnas.0707452104
26. Hu C. D., Chinenov Y., Kerppola T. K., Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Molecular Cell 2002 9 4 789 798 2-s2.0-0036241055 10.1016/S1097-2765(02)00496-3
27. Kerppola T. K., Visualization of molecular interactions by fluorescence complementation. Nature Reviews Molecular Cell Biology 2006 7 6 449 456 2-s2.0-33745785300 10.1038/nrm1929
28. Kerppola T. K., Bimolecular fluorescence complementation: visualization of molecular interactions in living cells. Methods in Cell Biology 2008 85 431 470 2-s2.0-37249010179 10.1016/S0091-679X(08)85019-4
29. MacDonald M. L., Lamerdin J., Owens S., Keon B. H., Bilter G. K., Shang Z., Huang Z., Yu H., Dias J., Minami T., Michnick S. W., Westwick J. K., Identifying off-target effects and hidden phenotypes of drugs in human cells. Nature Chemical Biology 2006 2 6 329 337 2-s2.0-33646893689 10.1038/nchembio790
30. Nagai T., Ibata K., Park E. S., Kubota M., Mikoshiba K., Miyawaki A., A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nature Biotechnology 2002 20 1 87 90 2-s2.0-0036138908 10.1038/nbt0102-87
31. Yu H., West M., Keon B. H., Bilter G. K., Owens S., Lamerdin J., Westwick J. K., Measuring drug action in the cellular context using protein-fragment complementation assays. Assay Drug Dev Technol 2003 1 6 811 822 2-s2.0-3343014678
32. Liu Y., Stone S., Harty R. N., Characterization of filovirus protein-protein interactions in mammalian cells using bimolecular complementation. The Journal of Infectious Diseases. In press
33. Harty R. N., No exit: targeting the budding process to inhibit filovirus replication. Antiviral Research 2009 81 3 189 197 2-s2.0-60249086364 10.1016/j.antiviral.2008.12.003
34. Tavassoli A., Lu Q., Gam J., Pan H., Benkovic S. J., Cohen S. N., Inhibition of HIV budding by a genetically selected cyclic peptide targeting the Gag-TSG101 interaction. ACS Chemical Biology 2008 3 12 757 764 2-s2.0-58949086238 10.1021/cb800193n
35. Waheed A. A., Freed E. O., Peptide inhibitors of HIV-1 egress. ACS Chemical Biology 2008 3 12 745 747 2-s2.0-58949095359 10.1021/cb800296j
36. Irwin J. J., Shoichet B. K., ZINCa free database of commercially available compounds for virtual screening. Journal of Chemical Information and Modeling 2005 45 1 177 182 2-s2.0-13844312649 10.1021/ci049714+
37. Pornillos O., Alam S. L., Davis D. R., Sundquist W. I., Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein. Nature Structural Biology 2002 9 11 812 817 2-s2.0-0036829172
38. Morris G. M., Ruth H., Lindstrom W., Sanner M. F., Belew R. K., Goodsell D. S., Olson A. J., Software news and updates AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. Journal of Computational Chemistry 2009 30 16 2785 2791 2-s2.0-70349932423 10.1002/jcc.21256
39. Zhang S., Kumar K., Jiang X., Wallqvist A., Reifman J., DOVIS: an implementation for high-throughput virtual screening using AutoDock. BMC Bioinformatics 2008 9, article 126 2-s2.0-40749120187 10.1186/1471-2105-9-126
40. Brooks B. R., Brooks C. L., Mackerell A. D., Nilsson L., Petrella R. J., Roux B., Won Y., Archontis G., Bartels C., Boresch S., Caflisch A., Caves L., Cui Q., Dinner A. R., Feig M., Fischer S., Gao J., Hodoscek M., Im W., Kuczera K., Lazaridis T., Ma J., Ovchinnikov V., Paci E., Pastor R. W., Post C. B., Pu J. Z., Schaefer M., Tidor B., Venable R. M., Woodcock H. L., Wu X., Yang W., York D. M., Karplus M., CHARMM: the biomolecular simulation program. Journal of Computational Chemistry 2009 30 10 1545 1614 2-s2.0-67650500988 10.1002/jcc.21287
41. Halgren T. A., Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. Journal of Computational Chemistry 1996 17 5-6 490 519 2-s2.0-0037571112
42. Krammer A., Kirchhoff P. D., Jiang X., Venkatachalam C. M., Waldman M., LigScore: a novel scoring function for predicting binding affinities. Journal of Molecular Graphics and Modelling 2005 23 5 395 407 2-s2.0-15244346501 10.1016/j.jmgm.2004.11.007
43. Han Z., ziyinghan@yahoo.com Harty R. N., rharty@vet.upenn.edu Packaging of actin into Ebola virus VLPs. Virology Journal 2005 2, article 92 10.1186/1743-422X-2-92
44. Ruthel G., Demmin G. L., Kallstrom G., Javid M. P., Badie S. S., Will A. B., Nelle T., Schokman R., Nguyen T. L., Carra J. H., Bavari S., Aman M. J., amanm@ncifcrf.gov Association of Ebola virus matrix protein Vp40 with microtubules. The Journal of Virology 2005 79 8 4709 4719 10.1128/JVI.79.8.4709- 4719.2005
45. Aman M. J., Kinch M. S., Warfield K., Warren T., Yunus A., Enterlein S., Stavale E., Wang P., Chang S., Tang Q., Porter K., Goldblatt M., Bavari S., Development of a broad-spectrum antiviral with activity against Ebola virus. Antiviral Research 2009 83 3 245 251 2-s2.0-68249131770 10.1016/j.antiviral. 2009.06.001
46. Kinch M. S., Yunus A. S., Lear C., Mao H., Chen H., Fesseha Z., Luo G., Nelson E. A., Li L., Huang Z., Murray M., Ellis W. Y., Hensley L., Christopher-Hennings J., Olinger G. G., Goldblatt M., FGI-104: a broad-spectrum small molecule inhibitor of viral infection. American Journal of Translational Research 2009 1 1 87 98 2-s2.0-68249120051
47. Radoshitzky S. R., Warfield K. L., Chi X., Ebolavirus Δ-peptide immunoadhesins inhibit Marburgvirus and Ebolavirus cell entry. The Journal of Virology 2011 85 17 8502 8513 10.1128/JVI.02600-10
48. Miller E. H., Harrison J. S., Radoshitzky S. R., Higgins C. D., Chi X., Dong L., Kuhn J. H., Bavari S., Lai J. R., jon.lai@einstein.yu.edu Chandran K., kartik.chandran@einstein.yu.edu Inhibition of Ebola virus entry by a C-peptide targeted to endosomes. The Journal of Biological Chemistry 2011 286 18 15854 15861 10.1074/jbc.M110.207084
49. Basu A., abasu@microbiotix.com Li B., Mills D. M., Panchal R. G., Cardinale S. C., Butler M. M., Peet N. P., Majgier-Baranowska H., Williams J. D., Patel I., Moir D. T., Bavari S., Ray R., Farzan M. R., Rong L., Bowlin T. L., Identification of a small-molecule entry inhibitor for filoviruses. The Journal of Virology 2011 85 7 3106 3119 10.1128/JVI.01456-10
50. Capul A. A., de la Torre J. C., A cell-based luciferase assay amenable to high-throughput screening of inhibitors of arenavirus budding. Virology 2008 382 1 107 114 2-s2.0-55249103820 10.1016/j.virol.2008.09.008
51. Deng Z., Chuaqui C., Singh J., Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions. Journal of Medicinal Chemistry 2004 47 2 337 344 2-s2.0-0346962971 10.1021/jm030331x
52. Hoenen T., Biedenkopf N., Zielecki F., Jung S., Groseth A., Feldmann H., Becker S., Oligomerization of ebola virus VP40 is essential for particle morphogenesis and regulation of viral transcription. The Journal of Virology 2010 84 14 7053 7063 2-s2.0-77953742423 10.1128/JVI.00737-10